David Crain represents public and private companies and investors in connection with a variety of corporate and financial matters, including general corporate governance, mergers and acquisitions, and private equity investing, with a particular focus on life science matters.

Mr. Crain graduated from the New York University School of Law, where he was an editor for the Journal of Law and Business and a member of the Business Transactions Clinic.


  • AstraZeneca in connection with global supply agreements related to the AstraZeneca COVID-19 vaccine.


  • BA, History, Stony Brook University, 2015
  • JD, New York University, 2020, cum laude
  • New York

Email Disclaimer